TFF PHARMACEUTICALS, INC. Deferred Offering Costs
TFF PHARMACEUTICALS, INC. had Deferred Offering Costs of $159.00 thousand as of 2022-06-30, per its 10-Q filed 2022-08-11.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2022-08-11
- 2022-06-30: Deferred Offering Costs $159.00K.
- 2019-09-30: Deferred Offering Costs $461.89K.
- 2018-12-31: Deferred Offering Costs $127.77K.
| Period end | Deferred Offering Costs |
|---|---|
| 2022-06-30 | $159.00K 10-Q · filed 2022-08-11 |
| 2019-09-30 | $461.89K 10-Q · filed 2019-12-09 |
| 2018-12-31 | $127.77K 10-K · filed 2020-03-27 |